Selected research
Market Outlook & Growth Opportunities
Global GMP-grade AAV Vector Manufacturing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global GMP-grade AAV Vector Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for GMP-grade AAV Vector Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GMP-grade AAV Vector Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP-grade AAV Vector Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the GMP-grade AAV Vector Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the GMP-grade AAV Vector Manufacturing Service market include Catalent, AGC Biologics, SK pharmteco, OXB, Forge Biologics, Viralgen, Andelyn Biosciences, Resilience and Advanced Therapies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global GMP-grade AAV Vector Manufacturing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP-grade AAV Vector Manufacturing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP-grade AAV Vector Manufacturing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global GMP-grade AAV Vector Manufacturing Service market.
GMP-grade AAV Vector Manufacturing Service Segment by Company
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Resilience
Advanced Therapies
IDT Biologika
Matica Bio
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech
Thermo Fisher Scientific
Lonza
Charles River Laboratories
GMP-grade AAV Vector Manufacturing Service Segment by Type
GMP Drug Substance Manufacturing
GMP Drug Substance and Fill-Finish
End-to-End CMC and Manufacturing
GMP-grade AAV Vector Manufacturing Service Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Other
GMP-grade AAV Vector Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global GMP-grade AAV Vector Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the GMP-grade AAV Vector Manufacturing Service key companies, revenue, market share, and recent developments.
3. To split the GMP-grade AAV Vector Manufacturing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions GMP-grade AAV Vector Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify GMP-grade AAV Vector Manufacturing Service significant trends, drivers, influence factors in global and regions.
6. To analyze GMP-grade AAV Vector Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP-grade AAV Vector Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP-grade AAV Vector Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP-grade AAV Vector Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP-grade AAV Vector Manufacturing Service industry.
Chapter 3: Detailed analysis of GMP-grade AAV Vector Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of GMP-grade AAV Vector Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of GMP-grade AAV Vector Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- GMP Drug Substance Manufacturing
- GMP Drug Substance and Fill-Finish
- End-to-End CMC and Manufacturing
Applications
- Biotechnology Companies
- Pharmaceutical Companies
- Other
Companies covered
- Catalent
- AGC Biologics
- SK pharmteco
- OXB
- Forge Biologics
- Viralgen
- Andelyn Biosciences
- Resilience
- Advanced Therapies
- IDT Biologika
- Matica Bio
- Takara Bio
- VectorBuilder
- GenScript ProBio
- PackGene Biotech
- Thermo Fisher Scientific
- Lonza
- Charles River Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global GMP-grade AAV Vector Manufacturing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global GMP-grade AAV Vector Manufacturing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 GMP-grade AAV Vector Manufacturing Service Market Dynamics
- 2.1 GMP-grade AAV Vector Manufacturing Service Industry Trends
- 2.2 GMP-grade AAV Vector Manufacturing Service Industry Drivers
- 2.3 GMP-grade AAV Vector Manufacturing Service Industry Opportunities and Challenges
- 2.4 GMP-grade AAV Vector Manufacturing Service Industry Restraints
3 GMP-grade AAV Vector Manufacturing Service Market by Company
- 3.1 Global GMP-grade AAV Vector Manufacturing Service Company Revenue Ranking in 2025
- 3.2 Global GMP-grade AAV Vector Manufacturing Service Revenue by Company (2021-2026)
- 3.3 Global GMP-grade AAV Vector Manufacturing Service Company Ranking (2024-2026)
- 3.4 Global GMP-grade AAV Vector Manufacturing Service Company Manufacturing Base and Headquarters
- 3.5 Global GMP-grade AAV Vector Manufacturing Service Company Product Type and Application
- 3.6 Global GMP-grade AAV Vector Manufacturing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global GMP-grade AAV Vector Manufacturing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 GMP-grade AAV Vector Manufacturing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 GMP-grade AAV Vector Manufacturing Service Market by Type
- 4.1 GMP-grade AAV Vector Manufacturing Service Type Introduction
- 4.1.1 GMP Drug Substance Manufacturing
- 4.1.2 GMP Drug Substance and Fill-Finish
- 4.1.3 End-to-End CMC and Manufacturing
- 4.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type
- 4.2.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (2021-2032)
- 4.2.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type (2021-2032)
5 GMP-grade AAV Vector Manufacturing Service Market by Application
- 5.1 GMP-grade AAV Vector Manufacturing Service Application Introduction
- 5.1.1 Biotechnology Companies
- 5.1.2 Pharmaceutical Companies
- 5.1.3 Other
- 5.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application
- 5.2.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (2021-2032)
- 5.2.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application (2021-2032)
6 GMP-grade AAV Vector Manufacturing Service Regional Value Analysis
- 6.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (2021-2032)
- 6.2.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region: 2021-2026
- 6.2.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GMP-grade AAV Vector Manufacturing Service Sales Value (2021-2032)
- 6.3.2 North America GMP-grade AAV Vector Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe GMP-grade AAV Vector Manufacturing Service Sales Value (2021-2032)
- 6.4.2 Europe GMP-grade AAV Vector Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America GMP-grade AAV Vector Manufacturing Service Sales Value (2021-2032)
- 6.6.2 South America GMP-grade AAV Vector Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value Share by Country, 2025 VS 2032
7 GMP-grade AAV Vector Manufacturing Service Country-level Value Analysis
- 7.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Country (2021-2032)
- 7.2.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Country (2021-2026)
- 7.2.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt GMP-grade AAV Vector Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt GMP-grade AAV Vector Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt GMP-grade AAV Vector Manufacturing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Catalent
- 8.1.1 Catalent Company Information
- 8.1.2 Catalent Business Overview
- 8.1.3 Catalent GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Catalent GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.1.5 Catalent Recent Developments
- 8.2 AGC Biologics
- 8.2.1 AGC Biologics Company Information
- 8.2.2 AGC Biologics Business Overview
- 8.2.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.2.5 AGC Biologics Recent Developments
- 8.3 SK pharmteco
- 8.3.1 SK pharmteco Company Information
- 8.3.2 SK pharmteco Business Overview
- 8.3.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.3.5 SK pharmteco Recent Developments
- 8.4 OXB
- 8.4.1 OXB Company Information
- 8.4.2 OXB Business Overview
- 8.4.3 OXB GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 OXB GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.4.5 OXB Recent Developments
- 8.5 Forge Biologics
- 8.5.1 Forge Biologics Company Information
- 8.5.2 Forge Biologics Business Overview
- 8.5.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.5.5 Forge Biologics Recent Developments
- 8.6 Viralgen
- 8.6.1 Viralgen Company Information
- 8.6.2 Viralgen Business Overview
- 8.6.3 Viralgen GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Viralgen GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.6.5 Viralgen Recent Developments
- 8.7 Andelyn Biosciences
- 8.7.1 Andelyn Biosciences Company Information
- 8.7.2 Andelyn Biosciences Business Overview
- 8.7.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.7.5 Andelyn Biosciences Recent Developments
- 8.8 Resilience
- 8.8.1 Resilience Company Information
- 8.8.2 Resilience Business Overview
- 8.8.3 Resilience GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Resilience GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.8.5 Resilience Recent Developments
- 8.9 Advanced Therapies
- 8.9.1 Advanced Therapies Company Information
- 8.9.2 Advanced Therapies Business Overview
- 8.9.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.9.5 Advanced Therapies Recent Developments
- 8.10 IDT Biologika
- 8.10.1 IDT Biologika Company Information
- 8.10.2 IDT Biologika Business Overview
- 8.10.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.10.5 IDT Biologika Recent Developments
- 8.11 Matica Bio
- 8.11.1 Matica Bio Company Information
- 8.11.2 Matica Bio Business Overview
- 8.11.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.11.5 Matica Bio Recent Developments
- 8.12 Takara Bio
- 8.12.1 Takara Bio Company Information
- 8.12.2 Takara Bio Business Overview
- 8.12.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.12.5 Takara Bio Recent Developments
- 8.13 VectorBuilder
- 8.13.1 VectorBuilder Company Information
- 8.13.2 VectorBuilder Business Overview
- 8.13.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.13.5 VectorBuilder Recent Developments
- 8.14 GenScript ProBio
- 8.14.1 GenScript ProBio Company Information
- 8.14.2 GenScript ProBio Business Overview
- 8.14.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.14.5 GenScript ProBio Recent Developments
- 8.15 PackGene Biotech
- 8.15.1 PackGene Biotech Company Information
- 8.15.2 PackGene Biotech Business Overview
- 8.15.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.15.5 PackGene Biotech Recent Developments
- 8.16 Thermo Fisher Scientific
- 8.16.1 Thermo Fisher Scientific Company Information
- 8.16.2 Thermo Fisher Scientific Business Overview
- 8.16.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.16.5 Thermo Fisher Scientific Recent Developments
- 8.17 Lonza
- 8.17.1 Lonza Company Information
- 8.17.2 Lonza Business Overview
- 8.17.3 Lonza GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Lonza GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.17.5 Lonza Recent Developments
- 8.18 Charles River Laboratories
- 8.18.1 Charles River Laboratories Company Information
- 8.18.2 Charles River Laboratories Business Overview
- 8.18.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 8.18.5 Charles River Laboratories Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst